Literature DB >> 21719097

New hope for immune intervention therapy in type 1 diabetes.

Bart O Roep1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21719097     DOI: 10.1016/S0140-6736(11)60977-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  The problems and promises of research into human immunology and autoimmune disease.

Authors:  Bart O Roep; Jane Buckner; Stephen Sawcer; Rene Toes; Frauke Zipp
Journal:  Nat Med       Date:  2012-01-06       Impact factor: 53.440

Review 2.  Functional Impact of Risk Gene Variants on the Autoimmune Responses in Type 1 Diabetes.

Authors:  Chelsea Gootjes; Jaap Jan Zwaginga; Bart O Roep; Tatjana Nikolic
Journal:  Front Immunol       Date:  2022-05-04       Impact factor: 8.786

3.  Peripheral blood monocyte gene expression profile clinically stratifies patients with recent-onset type 1 diabetes.

Authors:  Katharine M Irvine; Patricia Gallego; Xiaoyu An; Shannon E Best; Gethin Thomas; Christine Wells; Mark Harris; Andrew Cotterill; Ranjeny Thomas
Journal:  Diabetes       Date:  2012-03-08       Impact factor: 9.461

Review 4.  From Disease and Patient Heterogeneity to Precision Medicine in Type 1 Diabetes.

Authors:  Nicoline H M den Hollander; Bart O Roep
Journal:  Front Med (Lausanne)       Date:  2022-07-12

Review 5.  Immune modulation in humans: implications for type 1 diabetes mellitus.

Authors:  Bart O Roep; Timothy I M Tree
Journal:  Nat Rev Endocrinol       Date:  2014-01-28       Impact factor: 43.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.